|
Revenue
|
| | -1.01M |
|
Research & Development
|
2.28M | 1.61M | 2.47M |
|
Selling, General & Administrative
|
6.46M | 8.52M | 7.15M |
|
Restructuring Costs
|
| 8.20M | 6.76M |
|
Other Operating Expenses
|
| -8.20M | -6.76M |
|
Operating Expenses
|
8.74M | 10.13M | 9.63M |
|
Operating Income
|
-8.74M | -10.13M | -9.63M |
|
EBIT
|
-8.74M | -10.13M | -9.63M |
|
Other Non Operating Income
|
5.39M | 0.17M | 3.02M |
|
EBT
|
-4.64M | -9.87M | -9.33M |
|
Profit After Tax
|
-4.64M | -9.84M | -9.30M |
|
Income from Continuing Operations
|
-4.64M | -9.87M | -9.33M |
|
Consolidated Net Income
|
-4.64M | -9.87M | -9.33M |
|
Income towards Parent Company
|
-4.64M | -9.87M | -9.33M |
|
Net Income towards Common Stockholders
|
-4.64M | -9.87M | -9.33M |
|
EPS (Basic)
|
-0.57 | -16.61 | -7.40 |
|
EPS (Weighted Average and Diluted)
|
-0.57 | -16.61 | -7.40 |
|
Shares Outstanding (Weighted Average)
|
0.00M | 0.00M | 0.01M |
|
EBITDA
|
-8.74M | -10.13M | -9.63M |
|
Interest Expenses
|
| | 1.01M |